DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Innovision Limited — Awarding of order(s)/contract(s)

NSE 1 hr ago·8 Sept 2026, 11:23 am

Innovision

Innovision Limited has announced the awarding of new orders or contracts, marking a significant development for the company. This news signals that the company is actively securing new business, which is a positive indicator of its operational momentum and market demand.

For investors, this development is generally viewed favorably as it suggests growth potential and an expanding order book. It implies that the company is successfully competing for projects, which could lead to increased revenue streams in the future.

Investors should monitor the specific value and duration of these new contracts to better gauge their impact on the company's financial performance. Keeping an eye on future order announcements will also help assess the company's sustained growth trajectory.